Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
Author:
TSILIMIGRAS DIAMANTIS I.,THANOPOULOU KALLIOPI,SALAGIANNI MARIA,SIASOS GERASIMOS,OIKONOMOU EVANGELOS,PERREA DESPINA D.,NIRAKIS NIKOLAOS,FILIS KONSTANTINOS,TSIOUFIS KONSTANTINOS,TOUSOULIS DIMITRIOS,SIGALA FRAGISKA
Publisher
Anticancer Research USA Inc.
Subject
Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research